Medicalising unhappiness: new classification of depression risks more patients being put on drug treatment from which they will not benefit.

Medicalising unhappiness: new classification of depression risks more patients being put on drug treatment from which they will not benefit. - PDF Download Free
246KB Sizes 0 Downloads 0 Views

Recommend Documents


Integration of primary health services: being put together does not mean they will work together.
This paper reports on an Australian experience of co-locating a range of different primary health services into one building, with the aim of providing integrated services. It discusses some of the early challenges involved with moving services toget

New hospital food standards 'will put nurses in difficult position'.
Hospital nurses will not be able to comply with mandatory standards to ensure patients have healthy and nutritious food unless they receive more support, the RCN has warned.

Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit.
This is a review of hypnotic drug risks and benefits, reassessing and updating advice presented to the Commissioner of the Food and Drug Administration (United States FDA). Almost every month, new information appears about the risks of hypnotics (sle

Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder.
Personalizing treatment for late-life depression requires identifying and integrating information from multiple factors that influence treatment efficacy (moderators). We performed exploratory moderator analyses using data from a multi-site, randomiz

Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer?
In patients with cancer of the pancreatic head, metastasis to para-aortic lymph nodes (LN16) is considered distant metastasis and a poor prognostic marker. However, the incidence of LN16 involvement in pancreatic head cancer is high, and it is unclea